Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatment
Future Medicinal Chemistry Editorial by Daniel Merk (Goethe University Frankfurt, Germany) discussing the potential of retinoid X receptor gamma-targeting agents to repair or reverse multiple sclerosis damage to the CNS through boosting remyelination.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>